Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Efficacy and safety of isatuximab subcutaneous plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma: results of the Phase 2 study IZALCO

Title:	Efficacy and safety of isatuximab subcutaneous plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma: results of the Phase 2 study IZALCO
Authors:	Parmar, Gurdeep^{Aff1, IDs41408025014360_cor1}; Capra, Marcelo^Aff2; Seguro, Fernanda^Aff3; Hungria, Vania^Aff4; Dimopoulos, Meletios-Athanasios^{Aff5, Aff6}; Delimpasi, Sosana^Aff7; Minařík, Jiří^Aff8; Špička, Ivan^Aff9; Pour, Luděk^Aff10; Marques, Herlander^Aff11; Esteves, Graça^Aff12; Sunami, Kazutaka^Aff13; Yuda, Junichiro^Aff14; Hájek, Roman^Aff15; Mihályová, Jana^Aff15; Soufflet, Christine^Aff16; Yu, Disa^Aff17; Benlhassan, Khadija^Aff18; Koch, Victorine^Aff18; Comerford, Erin^Aff17; Cordero, Paul^Aff19; Suzan, Florence^Aff16; Quach, Hang^Aff20
Source:	Blood Cancer Journal. 16(1)
Database:	Springer Nature Journals